MeiraGTx Holdings (MGTX) Income from Continuing Operations (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Income from Continuing Operations of 15892000.0 for Q4 2025, up 132.46% on a QoQ basis from 48955000.0 in Q3 2025, and up 149.36% year-over-year from 6373150.04 in Q4 2024.
MeiraGTx Holdings (MGTX) Income from Continuing Operations (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 15892000.0 for Q4 2025.
- Quarterly Income from Continuing Operations rose 149.36% year-over-year to 15892000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 122110000.0 (up 29.69% YoY) and the FY2025 annual result came in at 287191000.0, up 7.19% from the prior year.
- Income from Continuing Operations was 15892000.0 for Q4 2025 at MeiraGTx Holdings, up from 48955000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 15892000.0 in Q4 2025 and bottomed at 51047000.0 in Q2 2024.
- A 5-year average of 29348900.0 and a median of 31841000.0 in 2023 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations plunged 927.97% — and 2025, when it soared 149.36%.
- MeiraGTx Holdings' Income from Continuing Operations stood at 4276000.0 in 2021, then plunged by 927.97% to 43956000.0 in 2022, then soared by 114.9% to 6549000.0 in 2023, then slumped by 591.63% to 32197000.0 in 2024, then surged by 149.36% to 15892000.0 in 2025.
- Business Quant data shows MGTX's Income from Continuing Operations at 15892000.0 in Q4 2025, 48955000.0 in Q3 2025, and 41421000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 15.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.89 Mn |
| Sep 30, 2025 | -48.96 Mn |
| Jun 30, 2025 | -41.42 Mn |
| Mar 31, 2025 | -47.63 Mn |
| Dec 31, 2024 | -32.20 Mn |
| Sep 30, 2024 | -41.50 Mn |
| Jun 30, 2024 | -51.05 Mn |
| Mar 31, 2024 | -48.93 Mn |
| Dec 31, 2023 | 6.55 Mn |
| Sep 30, 2023 | -35.62 Mn |
| Jun 30, 2023 | -31.49 Mn |
| Mar 31, 2023 | -34.28 Mn |
| Dec 31, 2022 | -43.96 Mn |
| Sep 30, 2022 | -24.41 Mn |
| Jun 30, 2022 | -25.08 Mn |
| Mar 31, 2022 | -30.09 Mn |
| Dec 31, 2021 | -4.28 Mn |
| Sep 30, 2021 | -23.75 Mn |
| Jun 30, 2021 | -21.67 Mn |
| Mar 31, 2021 | -23.13 Mn |